跳至主要内容
临床试验/NL-OMON35537
NL-OMON35537已完成4 期

ew influenza A (H1N1) disease incidence and immunogenicity of the pandemic influenza A(H1N1) vaccine in healthy adults - Incidence of new H1N1 influenza and its vaccine immunogenicity

Registratie en Medische Unit0 个研究点目标入组 375 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
375

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * good self-reported health according to the investigator
  • * willingness and ability to adhere to the study regimen
  • * having a signed informed consent form
  • * age 18 * 52 years

排除标准

  • The exclusion criteria with regard to contra-indications for receiving the pandemic influenza vaccine are:
  • * allergy to any of the components of the vaccine or trace residues of eggs, chicken proteins, kanamycin and neomycin sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB).
  • The exclusion criteria with regard to blood collection and the immunological analysis are:
  • * immune deficiencies
  • * haematological disorders
  • * bleeding disorders
  • * usage of anticoagulants, corticosteroids, NSAIDs and/or statins
  • * diabetes mellitus
  • * having had an infectious disease with fever within the last two weeks
  • * previously diagnosed with pandemic H1N1 influenza

研究者

发起方
Registratie en Medische Unit

相似试验